Lignox (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve cells, preventing the influx of sodium ions required for action potential generation. This interruption stops nerve impulse transmission, producing reversible numbness in the area where the product is applied.

The appropriate dose of Lignox is determined by the prescribing clinician based on the procedure, patient age, weight, and overall health. Healthcare professionals calculate the amount needed to achieve effective local anesthesia while minimizing systemic exposure.

Safety data for lidocaine hydrochloride in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against any possible risks and consider alternative treatments when appropriate. Consultation with a obstetrician or pediatrician is recommended.

To order Lignox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lignox (lidocaine) is a widely used amide‑type local anesthetic offering rapid onset and moderate duration of action. Compared with benzocaine, lidocaine provides deeper tissue penetration and a more predictable safety profile, while agents like benzocaine may have a higher risk of methemoglobinemia.

Lignox should be stored below 25 °C in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme temperatures that could compromise its stability.

Lignox is applied directly to the oral mucosa using the supplied applicator or swab. The clinician spreads a thin layer over the target area, allowing the medication to absorb and produce local anesthesia within minutes.

Serious risks include allergic reactions such as rash, angioedema, or anaphylaxis, and systemic lidocaine toxicity, which can manifest as dizziness, seizures, or cardiac arrhythmias. Immediate medical attention is required if any of these symptoms occur.

Individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid Lignox. Patients with severe cardiac conduction disorders, significant hepatic impairment, or those taking interacting medications listed under major interactions should also be evaluated carefully before use.